Snapshot from Aug 25, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Leerink Partners / Goldman Sachs

Leerink Partners & Goldman Sachs

3 shared events · Importance 3 · Last updated Aug 05, 2026

Importance
3
Shared Events
3
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
Shared Events (3)
55
Business
Twist Bioscience upsized $300M stock offering
Leerink Partners: Leerink Partners is a joint book-running manager, participating in the offering and earning fees.
Goldman Sachs: Goldman Sachs is a joint book-running manager, earning underwriting fees and enhancing its role in the biotech capital markets.
Aug 04, 2026 · 6 articles
40
Business
Scribe Therapeutics upsized IPO closes
Leerink Partners: Leerink Partners acted as a joint book-running manager for the IPO, earning fees and enhancing its reputation in biotech capital markets.
Goldman Sachs: Goldman Sachs served as a joint book-running manager, benefiting from the successful offering.
Jul 06, 2026 · 25 articles
12
Business
SpaceX first earnings report after IPO
Leerink Partners: Leerink Partners has a neutral rating and a $131 price target, citing regulatory and technology uncertainties.
Goldman Sachs: Goldman Sachs projects significant AI revenue for SpaceX by 2030, supporting its high valuation.
Jun 18, 2026 · 319 articles
ERGEN INTELLIGENCE
Explore this relationship live

Track how Leerink Partners and Goldman Sachs interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.